FLIDY Stock Chart - 1 Month
FLIDY Stock Chart - 3 Month
FLIDY Stock Chart - 6 Month
FLIDY Stock Chart - 1 Year
FLIDY Stock Chart - 2 Year
Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...
Continue Reading
Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...
Continue Reading
You can always count on some things staying the same, right? Well, if you thought red-eye flights were going to fade away, think again. These late-night wonders are not just hanging around—they're booming in the west like there's no tomorrow. Literally. Champion Traveler has laid it all out for us: about 115,580 overnight flights in 2025, a record high since this mad...
Continue Reading
Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...
Continue Reading
AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...
Continue Reading
Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....
Continue Reading
Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...
Continue Reading
Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...
Continue Reading
Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...
Continue Reading
Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...
Continue Reading
Meiji Seika Pharma Enhances Manufacturing Capabilities Meiji Seika Pharma Co., Ltd., known for its commitment to healthcare, has recently received exciting approval to expand its manufacturing and marketing capabilities for the innovative self-amplifying mRNA vaccine, KOSTAIVE®. This decision marks a significant milestone for the company as it strengthens the local...
Continue Reading
An Exciting Breakthrough in Osteosarcoma Treatment OS Therapies, Inc. (NYSE-A: OSTX), a pioneering biotechnology firm, has recently made waves in the oncology field by completing a Phase 2b clinical trial concerning its innovative treatment, OST-HER2. This trial aims to address the severe challenges faced by patients suffering from lung metastatic osteosarcoma - a rare...
Continue Reading
CEO Andy Byron Takes Leave Amidst Viral Coldplay Incident Astronomer CEO Andy Byron is currently on leave due to a controversial situation that unfolded during a Coldplay concert. A video that circulated online appears to show Byron embracing the company’s HR head, Kristin Cabot, which ignited a social media frenzy. The Viral Video's Impact The footage, which originated...
Continue Reading
Misunderstood Whiskey Launches Orange Blossom Bourbon Misunderstood Whiskey Co. has announced the launch of their eagerly awaited Orange Blossom Bourbon. This marks a significant milestone as it is the brand's first bourbon since it began in 2017. With this release, the company aims to revolutionize the flavored whiskey market by providing high-quality, infused options...
Continue Reading
Capital Flow Challenges for Emerging Economies The dynamics of capital flows have become a significant topic of discussion lately, with emerging markets facing potential hurdles that could alter their financial landscape dramatically. Recent insights from JPMorgan, an influential investment bank, shed light on these pressing issues. As economic policies shift globally,...
Continue Reading